Profil

Grégoire Mélanie

TERRA Research Centre

See author's contact details
Main Referenced Co-authors
Duysinx, Bernard  (3)
Fontaine, Alexis  (3)
Hamaïdia, Malik  (3)
Jamakhani, Majeed  (3)
Scherpereel, Arnaud (3)
Main Referenced Keywords
chemotherapy (2); eosinophils (2); Mesothelioma (2); Biochemistry, Genetics and Molecular Biology (all) (1); Charcot-leyden crystal protein (1);
Main Referenced Disciplines
Oncology (3)
Biotechnology (1)

Publications (total 4)

The most downloaded
52 downloads
Willems, M., Scherpereel, A., Wasielewski, E., Raskin, J., Brossel, H., Fontaine, A., Grégoire, M., Halkin, L., Jamakhani, M., Heinen, V., Louis, R., Duysinx, B., Hamaïdia, M.* , & Willems, L.*. (2023). Excess of blood eosinophils prior to therapy correlates with worse prognosis in mesothelioma. Frontiers in Immunology, 14, 1148798. doi:10.3389/fimmu.2023.1148798 https://hdl.handle.net/2268/303498

The most cited

2 citations (Scopus®)

Hartmann, F. S. F., Grégoire, M., Renzi, F., & Delvigne, F. (2024). Single cell technologies for monitoring protein secretion heterogeneity. Trends in Biotechnology. doi:10.1016/j.tibtech.2024.02.011 https://hdl.handle.net/2268/317039

Willems, M.* , Hamaïdia, M.* , Fontaine, A., Grégoire, M., Halkin, L., Vilanova Mana, L., Terres, R., Jamakhani, M., Deshayes, S., Brostaux, Y., HEINEN, V., LOUIS, R., Duysinx, B., Jean, D., Wasielewski, E., Scherpereel, A., Blanquart, C., & Willems, L. (28 October 2024). The impact of Charcot-Leyden Crystal protein on mesothelioma chemotherapy: targeting eosinophils for enhanced chemosensitivity. EBioMedicine, 109, 105418. doi:10.1016/j.ebiom.2024.105418
Peer Reviewed verified by ORBi
* These authors have contributed equally to this work.

Hartmann, F. S. F., Grégoire, M., Renzi, F., & Delvigne, F. (2024). Single cell technologies for monitoring protein secretion heterogeneity. Trends in Biotechnology. doi:10.1016/j.tibtech.2024.02.011
Peer Reviewed verified by ORBi

Willems, M., Scherpereel, A., Wasielewski, E., Raskin, J., Brossel, H., Fontaine, A., Grégoire, M., Halkin, L., Jamakhani, M., Heinen, V., Louis, R., Duysinx, B., Hamaïdia, M.* , & Willems, L.*. (2023). Excess of blood eosinophils prior to therapy correlates with worse prognosis in mesothelioma. Frontiers in Immunology, 14, 1148798. doi:10.3389/fimmu.2023.1148798
Peer Reviewed verified by ORBi
* These authors have contributed equally to this work.

Willems, M., Jamakhani, M., Scherpereel, A., Wasielewski, E., Brossel, H., Fontaine, A., Hoyos, C., Grégoire, M., Louis, R., Duysinx, B., Hamaïdia, M.* , & Willems, L.*. (14 December 2021). Eosinophils inhibit malignant pleural mesothelioma response to chemotherapy [Poster presentation]. GIGA-Cancer Day, Liège, Belgium.
* These authors have contributed equally to this work.

Contact ORBi